Finally, some really good news.
This is the study that the previous Board and CEO should have done years ago.
Anyway, this is progress. Hopefully other treatment centres come on Board quickly, but frankly because the Spanish have the most experience to date I'd be keen for them to do most of the patients. This study could potentially convince TGA too.
When the German study starts (also controlled from memory) that will be 2 real studies underway.
Both funded from either shareholders or ***.
Ann: First patient enrolled in the TRIPP-FFX Clinical Study, page-2
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $25.28K | 1.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 4747126 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 6365956 | 17 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |